Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients
Growing evidence shows that the immune system is critically involved in Alzheimer’s disease (AD) pathogenesis and progression. The modulation and targeting of peripheral immune mechanisms are thus promising therapeutic or preventive strategies for AD. Given the critical involvement of the endocannab...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/4/502 |
_version_ | 1797539900542681088 |
---|---|
author | Valerio Chiurchiù Lucia Scipioni Beatrice Arosio Daniela Mari Sergio Oddi Mauro Maccarrone |
author_facet | Valerio Chiurchiù Lucia Scipioni Beatrice Arosio Daniela Mari Sergio Oddi Mauro Maccarrone |
author_sort | Valerio Chiurchiù |
collection | DOAJ |
description | Growing evidence shows that the immune system is critically involved in Alzheimer’s disease (AD) pathogenesis and progression. The modulation and targeting of peripheral immune mechanisms are thus promising therapeutic or preventive strategies for AD. Given the critical involvement of the endocannabinoid (eCB) system in modulating immune functions, we investigated the potential role of the main elements of such a system, namely type-1 and type-2 cannabinoid receptors (CB<sub>1</sub> and CB<sub>2</sub>), and fatty acid amide hydrolase (FAAH), in distinct immune cell populations of the peripheral blood of AD patients. We found that, compared to healthy controls, CB<sub>1</sub> and CB<sub>2</sub> expression was significantly lower in the B-lymphocytes of AD patients. Moreover, we found that CB<sub>2</sub> was significantly lower and FAAH was significantly higher in monocytes of the same subjects. In contrast, T-lymphocytes and NK cells did not show any variation in any of these proteins. Of note, monocytic CB<sub>2</sub> and FAAH levels significantly correlated with clinical scores. Furthermore, the pharmacological inactivation of FAAH in monocytes and monocyte-derived macrophages obtained from AD patients was able to modulate their immune responses, by reducing production of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-12, and enhancing that of the anti-inflammatory cytokine IL-10. Furthermore, FAAH blockade skewed AD monocyte-derived macrophages towards a more anti-inflammatory and pro-resolving phenotype. Collectively, our findings highlight a central role of FAAH in regulating AD monocytes/macrophages that could be of value in developing novel monocyte-centered therapeutic approaches aimed at promoting a neuroprotective environment. |
first_indexed | 2024-03-10T12:52:21Z |
format | Article |
id | doaj.art-89b814bcc8ed4935903b355fc9e81eba |
institution | Directory Open Access Journal |
issn | 2218-273X |
language | English |
last_indexed | 2024-03-10T12:52:21Z |
publishDate | 2021-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomolecules |
spelling | doaj.art-89b814bcc8ed4935903b355fc9e81eba2023-11-21T12:58:58ZengMDPI AGBiomolecules2218-273X2021-03-0111450210.3390/biom11040502Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease PatientsValerio Chiurchiù0Lucia Scipioni1Beatrice Arosio2Daniela Mari3Sergio Oddi4Mauro Maccarrone5Institute of Translational Pharmacology, National Research Council (CNR), 00133 Rome, ItalyLaboratory of Neurochemistry of Lipids, European Center for Brain Research (CERC)/IRCCS Santa Lucia Foundation, 00143 Rome, ItalyGeriatric Unit, Fondazione Ca’ Granda, IRCCS Ospedale Maggiore Policlinico, 20122 Milan, ItalyGeriatric Unit, Fondazione Ca’ Granda, IRCCS Ospedale Maggiore Policlinico, 20122 Milan, ItalyLaboratory of Neurochemistry of Lipids, European Center for Brain Research (CERC)/IRCCS Santa Lucia Foundation, 00143 Rome, ItalyLaboratory of Neurochemistry of Lipids, European Center for Brain Research (CERC)/IRCCS Santa Lucia Foundation, 00143 Rome, ItalyGrowing evidence shows that the immune system is critically involved in Alzheimer’s disease (AD) pathogenesis and progression. The modulation and targeting of peripheral immune mechanisms are thus promising therapeutic or preventive strategies for AD. Given the critical involvement of the endocannabinoid (eCB) system in modulating immune functions, we investigated the potential role of the main elements of such a system, namely type-1 and type-2 cannabinoid receptors (CB<sub>1</sub> and CB<sub>2</sub>), and fatty acid amide hydrolase (FAAH), in distinct immune cell populations of the peripheral blood of AD patients. We found that, compared to healthy controls, CB<sub>1</sub> and CB<sub>2</sub> expression was significantly lower in the B-lymphocytes of AD patients. Moreover, we found that CB<sub>2</sub> was significantly lower and FAAH was significantly higher in monocytes of the same subjects. In contrast, T-lymphocytes and NK cells did not show any variation in any of these proteins. Of note, monocytic CB<sub>2</sub> and FAAH levels significantly correlated with clinical scores. Furthermore, the pharmacological inactivation of FAAH in monocytes and monocyte-derived macrophages obtained from AD patients was able to modulate their immune responses, by reducing production of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-12, and enhancing that of the anti-inflammatory cytokine IL-10. Furthermore, FAAH blockade skewed AD monocyte-derived macrophages towards a more anti-inflammatory and pro-resolving phenotype. Collectively, our findings highlight a central role of FAAH in regulating AD monocytes/macrophages that could be of value in developing novel monocyte-centered therapeutic approaches aimed at promoting a neuroprotective environment.https://www.mdpi.com/2218-273X/11/4/502Alzheimer’s diseasecytokinesfatty acid amide hydrolaseimmunomodulationmonocytes/macrophages |
spellingShingle | Valerio Chiurchiù Lucia Scipioni Beatrice Arosio Daniela Mari Sergio Oddi Mauro Maccarrone Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients Biomolecules Alzheimer’s disease cytokines fatty acid amide hydrolase immunomodulation monocytes/macrophages |
title | Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients |
title_full | Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients |
title_fullStr | Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients |
title_full_unstemmed | Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients |
title_short | Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients |
title_sort | anti inflammatory effects of fatty acid amide hydrolase inhibition in monocytes macrophages from alzheimer s disease patients |
topic | Alzheimer’s disease cytokines fatty acid amide hydrolase immunomodulation monocytes/macrophages |
url | https://www.mdpi.com/2218-273X/11/4/502 |
work_keys_str_mv | AT valeriochiurchiu antiinflammatoryeffectsoffattyacidamidehydrolaseinhibitioninmonocytesmacrophagesfromalzheimersdiseasepatients AT luciascipioni antiinflammatoryeffectsoffattyacidamidehydrolaseinhibitioninmonocytesmacrophagesfromalzheimersdiseasepatients AT beatricearosio antiinflammatoryeffectsoffattyacidamidehydrolaseinhibitioninmonocytesmacrophagesfromalzheimersdiseasepatients AT danielamari antiinflammatoryeffectsoffattyacidamidehydrolaseinhibitioninmonocytesmacrophagesfromalzheimersdiseasepatients AT sergiooddi antiinflammatoryeffectsoffattyacidamidehydrolaseinhibitioninmonocytesmacrophagesfromalzheimersdiseasepatients AT mauromaccarrone antiinflammatoryeffectsoffattyacidamidehydrolaseinhibitioninmonocytesmacrophagesfromalzheimersdiseasepatients |